| Inhibitory receptors and immune checkpoints regulating natural killer cell responses to cancer I Buckle, C Guillerey Cancers 13 (17), 4263, 2021 | 61 | 2021 |
| Regulatory T cells induced by single-peptide liposome immunotherapy suppress islet-specific T cell responses to multiple antigens and protect from autoimmune diabetes AS Bergot, I Buckle, S Cikaluru, JL Naranjo, CM Wright, G Zheng, ... The Journal of Immunology 204 (7), 1787-1797, 2020 | 51 | 2020 |
| Advanced glycation end products and inflammation in type 1 diabetes development C Du, RO Whiddett, I Buckle, C Chen, JM Forbes, AK Fotheringham Cells 11 (21), 3503, 2022 | 28 | 2022 |
| Reduced interleukin‐2 responsiveness impairs the ability of Treg cells to compete for IL‐2 in nonobese diabetic mice CR James, I Buckle, F Muscate, M Otsuka, M Nakao, JSH Oon, ... Immunology and Cell Biology 94 (5), 509-519, 2016 | 24 | 2016 |
| Tolerance induction by liposomes targeting a single CD8 epitope IGRP206–214 in a model of type 1 diabetes is impeded by co‐targeting a CD4+ islet epitope I Buckle, JD Loaiza Naranjo, AS Bergot, V Zhang, M Talekar, RJ Steptoe, ... Immunology and Cell Biology 100 (1), 33-48, 2022 | 10 | 2022 |
| A Question of Tolerance—Antigen-Specific Immunotherapy for Type 1 Diabetes JD Loaiza Naranjo, AS Bergot, I Buckle, EE Hamilton-Williams Current diabetes reports 20, 1-13, 2020 | 10 | 2020 |
| High dimensional analysis reveals distinct NK cell subsets but conserved response to stimulation in umbilical cord blood and adult peripheral blood I Buckle, A Johnson, IL Rojas, V Weinert, DP Sester, K Radford, ... European Journal of Immunology 53 (6), 2250118, 2023 | 6 | 2023 |
| The role of the receptor for advanced glycation endproducts (RAGE) in type 1 diabetes: an immune cell perspective I Buckle, JM Forbes Type 1 Diabetes in 2023-From Real Practice to Open Questions, 2022 | 1 | 2022 |
| Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis C Tu, I Buckle, I Leal Rojas, GR Rossi, DP Sester, AS Moore, K Radford, ... Clinical & Translational Immunology 13 (3), e1501, 2024 | | 2024 |
| REDOX MODULATING SMALL MOLECULE IMPROVES DIABETIC KIDNEY DISEASE IN THE DB/DB MODEL OF TYPE 2 DIABETES A Fotheringham, H Masagos, R Whiddett, D McCarthy, P Chandrashekar, ... Nephrology 28, 26-26, 2023 | | 2023 |
| Youth with type 1 diabetes at higher risk of developing diabetic kidney disease have alterations in their urine and plasma metabolomic and mitochondrial dna profiles M Sullivan, U Pham, D McCarthy, N Flemming, A Fotheringham, ... Nephrology 28, 28-29, 2023 | | 2023 |
| High dimensional flow cytometric analysis reveals distinct NK cell subsets but conserved response to cytokine stimulation in umbilical cord blood and adult peripheral blood I Buckle, V Weinert, DP Sester, K Radford, C Guillerey bioRxiv, 2022.07. 19.500730, 2022 | | 2022 |
| Antigen-specific peptide immunotherapy for treatment and prevention of type 1 diabetes I Buckle | | 2019 |
| Development of a model for antigen-specific tolerising immunotherapy and response in NOD mice I Buckle, RJ Steptoe, R Thomas, EE Hamilton-Williams European Journal of Immunology 46 (S1), 911-911, 2016 | | 2016 |
